During childhood and in adults, lesions typically involve the flexural aspects of the extremities. Subacute lesions of atopic dermatitis are typically scaly, erythematous, excoriated papules and ...

Atopic dermatitis is increasing in prevalence ... A history of a generally dry skin in the last year. Visible flexural dermatitis (or dermatitis involving the cheeks/forehead and outer of the ...

Question: My 11-year-old daughter has a very itchy scalp. I have checked for lice and found none, and even did a treatment to ...

Share on Pinterest A newly approved drug for the treatment of atopic dermatitis could make a big difference to people with moderate-to-severe eczema. Image credit: Sascha Lotz/picture alliance via ...

Topline results were announced from a phase 3 trial evaluating rocatinlimab for the treatment of moderate to severe atopic dermatitis.

Galderma today announced that it will present new data from the ARCADIA and OLYMPIA clinical trial programs investigating ...

Discover research presented at EADV 2024 highlighting the significant impact of atopic dermatitis on psychological and social ...

Atopic Dermatitis, commonly called Eczema, affects millions globally with cases rising in India. Misunderstandings about its ...

HORIZON Phase 3 trial evaluated rocatinlimab for atopic dermatitis (eczema) in 726 patients. Amgen reported that rocatinlimab outperformed a placebo regarding the severity and extent of the disease.

A new single-dose autoinjector presentation of Adbry is now available for use in the treatment of moderate to severe atopic dermatitis.

Union Therapeutics is looking to advance its PDE4 inhibitor, orismilast, into a Phase III clinical trial for atopic ...